Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron M Goodman

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 28, 2021
Intention to treat versus modified intention-to-treat analysis in B-cell maturation antigen and CD19 chimeric antigen receptor trials: A systematic review and meta-analysisGhulam Rehman Mohyuddin, Tahani Atieh, Nausheen Ahmed, et al.
NPJ Genomic Medicine|December 13, 2016
Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapySadakatsu Ikeda, Aaron M Goodman, Philip R Cohen, et al.
Molecular Cancer Therapeutics|August 25, 2017
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse CancersAaron M Goodman, Shumei Kato, Lyudmila Bazhenova, et al.
European Journal of Haematology|August 25, 2021
Novel somatic alterations in unicentric and idiopathic multicentric Castleman diseaseAaron M Goodman, Ah-Reum Jeong, Alexis Phillips, et al.
Iscience|January 19, 2026
Autoimmune HLA alleles and neoantigens predict myelodysplastic syndrome outcomes after allogeneic HSCT: A CIBMTR analysisTimothy Sears, Razelle Kurzrock, Tao Zhang, et al.
Cancer Immunology Research|April 21, 2019
Phenotypic and Genomic Determinants of Immunotherapy Response Associated with SquamousnessAaron M Goodman, Shumei Kato, Ranajoy Chattopadhyay, et al.
Journal of Immunotherapy and Precision Oncology|August 28, 2023
Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant RelapseAndrea Castro, Aaron M Goodman, Zachary Rane, et al.
Molecular Cancer Therapeutics|April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell HistiocytosisFilip Janku, Eli L Diamond, Aaron M Goodman, et al.
Ecancermedicalscience|July 3, 2023
Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activityManju Sengar, Wilma M Hopman, Ghulam Rehman Mohyuddin, et al.
Genome Medicine|May 21, 2020
MHC-I genotype and tumor mutational burden predict response to immunotherapyAaron M Goodman, Andrea Castro, Rachel Marty Pyke, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|August 28, 2021
Intention to treat versus modified intention-to-treat analysis in B-cell maturation antigen and CD19 chimeric antigen receptor trials: A systematic review and meta-analysisGhulam Rehman Mohyuddin, Tahani Atieh, Nausheen Ahmed, et al.
NPJ Genomic Medicine|December 13, 2016
Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapySadakatsu Ikeda, Aaron M Goodman, Philip R Cohen, et al.
Molecular Cancer Therapeutics|August 25, 2017
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse CancersAaron M Goodman, Shumei Kato, Lyudmila Bazhenova, et al.
European Journal of Haematology|August 25, 2021
Novel somatic alterations in unicentric and idiopathic multicentric Castleman diseaseAaron M Goodman, Ah-Reum Jeong, Alexis Phillips, et al.
Iscience|January 19, 2026
Autoimmune HLA alleles and neoantigens predict myelodysplastic syndrome outcomes after allogeneic HSCT: A CIBMTR analysisTimothy Sears, Razelle Kurzrock, Tao Zhang, et al.
Cancer Immunology Research|April 21, 2019
Phenotypic and Genomic Determinants of Immunotherapy Response Associated with SquamousnessAaron M Goodman, Shumei Kato, Ranajoy Chattopadhyay, et al.
Journal of Immunotherapy and Precision Oncology|August 28, 2023
Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant RelapseAndrea Castro, Aaron M Goodman, Zachary Rane, et al.
Molecular Cancer Therapeutics|April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell HistiocytosisFilip Janku, Eli L Diamond, Aaron M Goodman, et al.
Ecancermedicalscience|July 3, 2023
Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activityManju Sengar, Wilma M Hopman, Ghulam Rehman Mohyuddin, et al.
Genome Medicine|May 21, 2020
MHC-I genotype and tumor mutational burden predict response to immunotherapyAaron M Goodman, Andrea Castro, Rachel Marty Pyke, et al.
Pageof 8